| 1 |
32317681 | Mitigation of Tacrolimus-Associated Nephrotoxicity by PLGA Nanoparticulate Delivery Following Multiple Dosing to Mice while Maintaining its Immunosuppressive Activity. | 2020 Apr 21 |
1 |
| 2 |
31689461 | Inflammation-triggered local drug release ameliorates colitis by inhibiting dendritic cell migration and Th1/Th17 differentiation. | 2019 Dec 28 |
2 |
| 3 |
29316256 | Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice. | 2018 Jul |
1 |
| 4 |
26763872 | Teratocarcinomas Arising from Allogeneic Induced Pluripotent Stem Cell-Derived Cardiac Tissue Constructs Provoked Host Immune Rejection in Mice. | 2016 Jan 14 |
1 |
| 5 |
27644556 | Treatment with DHA/EPA ameliorates atopic dermatitis-like skin disease by blocking LTB4 production. | 2016 |
2 |
| 6 |
25770929 | Nordihydroguiaretic acid attenuates skin tumorigenesis in Swiss albino mice with the condition of topical co-administration of an immunosuppressant. | 2015 May 25 |
1 |
| 7 |
24836681 | Tolerogenic dendritic cells modified by tacrolimus suppress CD4(+) T-cell proliferation and inhibit collagen-induced arthritis in mice. | 2014 Jul |
2 |
| 8 |
21518963 | FK506 binding protein 12 deficiency in endothelial and hematopoietic cells decreases regulatory T cells and causes hypertension. | 2011 Jun |
2 |
| 9 |
19755159 | Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice. | 2010 Feb |
1 |
| 10 |
18656798 | Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development. | 2008 Aug |
1 |
| 11 |
12698107 | Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. | 2003 Apr 15 |
1 |
| 12 |
14632799 | Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. | 2003 Nov |
1 |
| 13 |
10836388 | Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade. | 2000 Apr 27 |
1 |
| 14 |
9566798 | The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction. | 1998 Apr |
1 |
| 15 |
7532685 | T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. | 1995 Mar 1 |
2 |
| 16 |
7543492 | FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. | 1995 Aug |
1 |
| 17 |
7521743 | FK506 inhibits the differentiation of developing thymocytes but not negative selection of T cell receptor V beta 5+ and V beta 11+ T lymphocytes in vivo. | 1994 |
4 |
| 18 |
1282000 | Down regulation of CD4 expression in cultured microglia by immunosuppressants and lipopolysaccharide. | 1992 Dec 15 |
1 |
| 19 |
1721313 | Kinetics of early T-cell repopulation in the mouse following syngeneic bone marrow transplantation: FK 506 causes a maturational defect of CD4+ CD8- T cells. | 1991 Dec |
1 |
| 20 |
1722778 | The influence of FK-506 on the thymus and spleen in normal C3H/He mice: flow cytometric analysis of lymphocyte subpopulations. | 1991 Aug |
1 |